COVID-19: Reasons not to use Avigan in South Korea: Korean Society for Infection / Central Clinical Committee
March 23, 2020
Korea Money Today:
reported why the anti-influenza virus drug “Avigan” used for treatment in Japan is not used in Korea.
Korean medical team:
Due to this “toxicity and side effects”, they are skeptical about the use of Avigan.
Korean Food and Drug Administration:
was considering an introduction plan to apply a special case to “Avigan which is not allowed to be used in Korea”.
However, it is said that the Disease Control Headquarters has not requested the use.
Korean Central Clinical Committee:
The papers published in the English chemistry journal “Nature” were analyzed.
As a result, “Avigan is ineffective in suppressing the new coronavirus, and the side effects are serious,”
Korean Infection Society
Korean Society for Antimicrobial Law
Korean Academy of Pediatric Infections
“Expert Recommendations for Drug Treatment of New Coronavirus” was announced.
However, it was said that Avigan was not included in it.
(Translation / editing / Matsumura)
International | News | So-net